Google Signs $3B Clean Energy Deal for Hydropower
Google has announced a major clean energy agreement with Brookfield Asset Management to secure up to 3 gigawatts of U.S. hydropower. This marks the world's largest corporate clean power pact for hydroelectricity to date.
The agreement includes 20-year power purchase contracts worth $3 billion. These contracts will support electricity generation from two hydropower facilities located in Pennsylvania. In addition, Google plans to invest $25 billion in data center infrastructure across Pennsylvania and nearby states over the next two years, according to a report by Semafor.
The clean energy deal reflects the growing demand for renewable electricity across the tech sector. Companies like Google are working to power energy-intensive data centers that support artificial intelligence and cloud computing. As a result, U.S. power consumption is rising after nearly two decades of relative stability.
Amanda Peterson Corio, Google's head of data center energy, said the collaboration with Brookfield is an important move to secure clean energy in the PJM region, where many of its data centers are located.
The latest agreement builds on Google's earlier efforts in renewable power. Over the past year, the company has signed several first-of-their-kind power purchase agreements. These include deals for carbon-free geothermal and advanced nuclear energy.
Moreover, Google is working with PJM Interconnection, the largest electricity grid operator in the U.S. The goal is to use artificial intelligence to speed up the process of integrating new clean energy supplies into the grid.
Brookfield, through its renewable energy arm Brookfield Renewable Partners, owns the two hydropower sites in Pennsylvania. Both facilities will be upgraded and relicensed under the new arrangement.
The framework agreement is expected to support Google's broader clean energy goals. The announcement comes ahead of an AI summit in Pittsburgh, where Alphabet President Ruth Porat is scheduled to speak.
According to reports, U.S. President Donald Trump will also attend the summit. The event is expected to include announcements of up to $70 billion in combined AI and energy investments.
Key highlights of the deal: 20-year hydropower purchase agreements totaling $3 billion
$25 billion investment in regional data centers
Upgrades and relicensing of two Pennsylvania hydropower sites
The agreement signals continued momentum in the tech industry's shift toward long-term clean energy solutions.
Source: Reuters
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Web Release
25 minutes ago
- Web Release
AI-ECG tools can help clinicians identify heart issues early in women planning to have children
Every year, some mothers die after giving birth due to heart problems, and many of these deaths could be prevented. The ability to screen for heart weakness before pregnancy could play a crucial role in identifying women who may need additional care to improve pregnancy outcomes. Mayo Clinic researchers, led by Anja Kinaszczuk, D.O., and Demilade Adedinsewo, M.B., Ch.B., tested artificial intelligence (AI) tools, using recordings from an electrocardiogram (ECG) and a digital stethoscope, to find unknown heart problems in women of childbearing age seen in primary care. Study findings published in the Annals of Family Medicine show high diagnostic performance of these technologies to detect left ventricular ejection fraction below 50%, indicating heart muscle weakness. These tools were tested on two groups of women aged 18 to 49: Group 1: 100 women already scheduled for an echocardiogram (the best test to evaluate heart muscle function). They also had a standard clinical ECG and digital stethoscope recording of the heart's electrical activity and heart sounds. Group 2: 100 women seen for routine primary care visits to see how often the AI tools would find heart problems. The AI-ECG demonstrated an area under the curve (AUC) of 0.94, while the AI digital stethoscope, Eko DUO, achieved an even higher AUC of 0.98, indicating strong diagnostic accuracy. In the second cohort, the prevalence of positive AI screening results was 1% for the AI-ECG and 3.2% for the AI-stethoscope. 'Statistically, nearly half of pregnancies in this country are unplanned, and approximately 1% to 2% of women may have heart problems they don't know about. Our research findings suggest that these AI tools could be used to screen women before pregnancy, allowing for improved pregnancy planning and risk stratification, early treatment, and better health outcomes which addresses a critical gap in current maternal care,' says Dr. Adedinsewo, a cardiologist and senior author of the study. This research builds upon earlier published studies, including a pilot prospective study evaluating AI digital tools to detect pregnancy-related cardiomyopathy among obstetric patients in the U.S. and a pragmatic randomized clinical trial of women in Nigeria who were pregnant or had recently given birth. Collectively, this research highlights the potential of AI to modernize cardiovascular screening, enabling earlier identification and management of heart muscle weakness in women of reproductive age. Further research is underway to explore the potential of using these technologies to screen for heart weakness in broader populations. Mayo Clinic has licensed the underlying technology to Eko Health for its digital stethoscope with embedded ECG electrodes and to Anumana for the 12-lead ECG. Mayo Clinic and some study authors have a financial interest in this technology. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research.
Web Release
25 minutes ago
- Web Release
Bain & Company forms strategic partnership with Dr. Andrew Ng to accelerate AI transformation for clients worldwide
Bain & Company today announced a strategic partnership with Dr. Andrew Ng and his advisory firm, AI Aspire, to help organizations unlock scalable, transformative value from artificial intelligence. Dr. Ng is a renowned British-American computer scientist, AI thought leader, and founder of The collaboration combines Bain's deep industry knowledge and expertise in AI implementation with Dr. Ng's pioneering insights in AI and machine learning, with the goal of empowering companies to move beyond experimentation and deliver enterprise-level results with AI. 'AI is the most transformative technology of our generation—and realizing its full potential requires both cutting-edge technical thinking and practical execution at scale,' said Chuck Whitten, senior partner and global head of Bain & Company's digital capabilities. 'That's what Bain does best. We're thrilled to welcome Andrew Ng—one of the foremost minds in AI—to our team, joining forces with our 1,500 AI and digital practitioners to help clients move from experimentation to enterprise-wide impact.' As demand for AI-enabled solutions accelerates, Bain has seen a sharp rise in client needs across sectors. Tech- and AI-enabled revenue now comprises approximately 30% of the firm's business, with expectations to grow to 50% in the coming years. 'I'm thrilled to partner with Bain & Company to make the best AI thinking accessible to leaders around the world,' said Dr. Andrew Ng. 'Companies that lack a thoughtful, strategic approach to AI risk falling far behind their competitors. This partnership is about equipping organizations to lead—not follow.' Bain's AI, Insights, and Solutions practice includes more than 1,500 AI, data, analytics, architecture, and engineering experts. This multidisciplinary team combines algorithmic, technical, and business expertise to solve business leaders' hardest problems. This includes machine learning application implementation, business insight delivery, technology architecture and engineering, organizational development, and analytics strategy. The group integrates closely with the firm's industry and capability practices to deliver holistic business and technology solutions. The firm has also significantly expanded its wider digital and AI ecosystem of partner organizations, including forming key alliances with OpenAI, Microsoft, AWS, Google, SAP, Salesforce, and IBM.
Tahawul Tech
an hour ago
- Tahawul Tech
Artificial Intelligence set to revolutionise healthcare's future, says Dr. Azad Moopen
Dubai — From an inundation in real-time data and its analysis, to a quantum leap in diagnosis and precision-guided solutions, Artificial Intelligence in health care is poised to be a complete game changer in the sector. The changes are there for everyone to see. In 2025 alone, global artificial intelligence (AI) in the healthcare market was valued at $39.25 billion, and it's expected to grow to $504.17 billion by 2032. That figure is more than a bullish forecast; it's a signpost pointing to the radical reimagining of healthcare as we know it. Across hospitals, clinics, and health tech labs from Abu Dhabi to Zimbabwe, AI is not just making inroads; it's redrawing the entire map of medicine. In the UAE, a nation committed to becoming a global leader in digital health, this revolution is being embraced with extraordinary speed. From robotic surgeries to AI-driven health records and predictive analytics, to the future of medicine, AI is here to stay. And it's making intelligent decisions that can make a difference between life and death. Especially around precision diagnosis. Reducing the margin of error A misdiagnosis can be fatal. Yet, diagnostic errors affect an estimated 12 million adults annually in the United States. That's where AI promises a quantum leap. Machine learning algorithms, fed on vast datasets of medical imaging, lab results, and patient histories, can detect abnormalities at a precision level humans simply cannot match. For example, Google Health's AI system has demonstrated greater accuracy than human radiologists in spotting breast cancer in mammograms. A landmark study published in Nature found that Google's deep learning AI reduced both false positives and false negatives compared to radiologists in both US and UK datasets. Meanwhile, DeepMind's AlphaFold, an AI system developed by the Google subsidiary, has cracked the protein folding problem, a breakthrough that could accelerate drug discovery and disease understanding exponentially. In the UAE, the Department of Health – Abu Dhabi (DoH) has launched Malaffi, the region's first Health Information Exchange, aiming to use AI to centralise and analyse patient data across providers. The ability to use this data to predict, rather than merely treat, illnesses could shift healthcare from a reactive to a preventive model. Diagnoses and resolution AI doesn't just diagnose; it also prescribes. Clinical decision support systems (CDSS) are now guiding doctors through labyrinths of data to arrive at the best course of treatment, not just generally, but for specific individuals. IBM Watson for Oncology, trained by oncologists at Memorial Sloan Kettering Cancer Center, has been assisting physicians globally by recommending personalised cancer treatments based on clinical evidence. 'In the UAE, AI is already augmenting healthcare through robot-assisted surgeries at hospitals like the Cleveland Clinic Abu Dhabi, Aster, Medcare, and Mediclinic. These systems offer precision, reducing recovery times and surgical risks.' Opening channels of accessibility to expertise But the real power lies in the democratisation of this expertise. Through cloud-based platforms and mobile apps, AI-driven diagnostics and treatment recommendations could soon be available even in remote regions of the world, addressing longstanding inequities in access to care. Imagine knowing you are likely to develop a certain disease, not from vague probabilities but with high certainty, years before any symptoms appear. That's not science fiction; that's predictive analytics – something AI can do with great precision. AI systems now analyse through reams of patient data, genomic information, and real-time wearable sensor data to identify at-risk individuals. For instance, Mount Sinai's AI research has produced significant advances, particularly in coronary artery disease prediction using electronic health records (EHRs) In the Gulf, where lifestyle-related diseases like Type 2 diabetes and cardiovascular issues are prevalent, such tools are not only welcome they are necessary. The Dubai Health Authority (DHA) is already piloting AI-based prediction models for chronic conditions, and wearable integration with digital health platforms is underway. The fusion of wearables with AI is particularly transformative. A UAE-based healthcare entity recently partnered with global tech players to pilot remote monitoring systems, allowing doctors to track patients' vitals in real time and intervene early turning reactive care into proactive protection. If the trends are any indication, the future hospital will not only treat patients better but run smarter. AI-powered logistics, staffing algorithms, and patient-flow management systems are already optimising operations, reducing wait times, and improving outcomes. In SEHA's flagship Sheikh Shakhbout Medical City, AI is being used to streamline triage and improve emergency room response times. Globally, institutions like Johns Hopkins Hospital in the U.S. are using predictive models to anticipate ICU demands, freeing up resources in advance and preventing crises. These smart hospitals are not just defined by flashy tech but by a philosophy: data-driven care that is seamless, efficient, and human-centric. Ethical Guardrails The AI-in-healthcare narrative isn't without its ethical dilemmas. Questions of data privacy, algorithmic bias, and accountability loom large. But that's where governance and regulation step in. In the UAE, the National Strategy for AI 2031 includes strong frameworks for ethical AI use, ensuring transparency, data protection, and oversight. Importantly, AI is not about replacing doctors but about enhancing their capacity. It frees clinicians from paperwork and routine diagnostics so they can focus on what machines can't replicate: compassion, creativity, and critical thinking. The question is not whether AI will change healthcare, but how boldly and responsibly we will embrace that change. This opinion piece is authored by Dr. Azad Moopen, Founder Chairman, Aster DM Healthcare.
